Objective
The development of effective novel drugs - especially for rare and neglected diseases - is one of the biggest challenges of the upcoming decades, as illustrated by the recent Ebola outbreak. Moreover, European innovation in new drug registrations is dramatically falling behind compared to the US and Asia.
The principal aim of the AEGIS ITN is to implement the first comprehensive, intersectoral cross-disciplinary and structured curriculum for doctoral students in the European Research Area by establishing a unique training platform for the next generation of European researchers in early drug discovery. A significant added value is provided through networking with key European pharmaceutical companies. A key research aim of AEGIS is improving the efficiency and success of early stage drug development by combining innovative methods and techniques to tackle difficult but promising targets (i.e. protein-protein interactions), as potentially valuable drug targets are often neglected due to the high risk associated with their validation.
The consortium joins leading academic and industry researchers in an open innovation environment for innovative drug development in Europe. It is supported by several additional partners and stakeholders in the field. Integrated training of the fellows takes place at the host institute and by secondments, research schools and individual training within the AEGIS network. The scientific training includes complementary skills, management, intellectual property rights, fund raising, communication and career planning. AEGIS will improve the availability of a highly skilled workforce for European industries and research, greatly enhance the employability and the career perspectives of young researchers for academia as well as for industry, and will be the seed of a sustainable development in innovative drug discovery, in particular for rare and neglected diseases.
Fields of science
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- medical and health sciencesbasic medicinemedicinal chemistry
- medical and health scienceshealth sciencesinfectious diseasesRNA virusesebola
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteins
- social scienceseconomics and businessbusiness and managementemployment
Programme(s)
Funding Scheme
MSCA-ITN-ETN - European Training NetworksCoordinator
85764 Neuherberg
Germany
See on map
Participants (10)
35037 Marburg
See on map
9712CP Groningen
See on map
751 05 Uppsala
See on map
75724 Paris
See on map
31-007 Krakow
See on map
8092 Zuerich
See on map
4056 Basel
See on map
74020 Vange
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
151 85 Sodertaelje
See on map
50129 FIRENZE
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partners (13)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
80539 Munchen
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
80333 Muenchen
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
02094 KYIV
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
28006 MADRID
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
31007 KRAKOW
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
75654 Paris
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
75014 Paris
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
85748 Garching
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
80331 München
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
50121 Florence
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
44801 Bochum
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
5612 AE Eindhoven
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
9712 JC Groningen
See on map